Cellebrite DI Ltd. - Ordinary Shares, par value 0.00001 NIS per share (CLBT) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2021 to Q4 2025

Type / Class
Equity / Ordinary Shares, par value 0.00001 NIS per share
Symbol
CLBT on Nasdaq
Shares outstanding
240,356,213
Price per share
$18.03
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
129,424,107
Total reported value
$2,398,195,670
% of total 13F portfolios
0.02%
Share change
+11,820,232
Value change
+$236,444,351
Number of holders
194
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Cellebrite DI Ltd. - Ordinary Shares, par value 0.00001 NIS per share (CLBT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SUNCORPORATION 44% $2,061,780,052 102,576,122 SUNCORPORATION 31 Dec 2024
TWC Tech Holdings II, LLC 6.1% $294,700,753 14,661,729 Adam H. Clammer 18 Mar 2025
FMR LLC 4.1% -22% $199,496,862 -$13,992,153 9,925,217 -6.6% FMR LLC 31 Mar 2025

As of 30 Sep 2025, 194 institutional investors reported holding 129,424,107 shares of Cellebrite DI Ltd. - Ordinary Shares, par value 0.00001 NIS per share (CLBT). This represents 54% of the company’s total 240,356,213 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Cellebrite DI Ltd. - Ordinary Shares, par value 0.00001 NIS per share (CLBT) together control 39% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
True Wind Capital Management, L.P. 5.8% 13,861,007 0% 94% $256,844,460
T. Rowe Price Investment Management, Inc. 4.2% 10,044,981 +54% 0.11% $186,134,000
Voss Capital, LP 2.8% 6,775,000 +32% 7.2% $125,540,750
FMR LLC 2.5% 6,060,856 -1.6% 0.01% $112,307,660
Invesco Ltd. 2.3% 5,560,196 +59% 0.02% $103,030,432
Pertento Partners LLP 1.9% 4,648,215 +58% 10% $86,131,424
Clal Insurance Enterprises Holdings Ltd 1.6% 3,913,014 0% 0.55% $72,508,000
BlackRock, Inc. 1.6% 3,731,544 +27% 0% $69,145,509
AXON ENTERPRISE, INC. 1.5% 3,679,375 -59% 100% $68,178,819
COOPER CREEK PARTNERS MANAGEMENT LLC 1.3% 3,022,086 2.1% $55,999,000
RENAISSANCE TECHNOLOGIES LLC 1.2% 2,902,105 +8% 0.07% $53,776,006
Handelsbanken Fonder AB 1.2% 2,900,000 +18% 0.17% $53,737,000
MORGAN STANLEY 1.2% 2,882,346 -38% 0% $53,409,872
Granahan Investment Management, LLC 1.1% 2,629,299 +1108% 2% $48,720,910
Phoenix Financial Ltd. 1% 2,507,096 +24% 0.57% $46,457,623
Nine Ten Capital Management LLC 1% 2,479,727 +17% 12% $45,949,000
Capital Research Global Investors 1% 2,425,736 +42% 0.01% $44,948,888
Portolan Capital Management, LLC 1% 2,419,662 +139% 2.4% $44,836,337
Nuveen, LLC 0.89% 2,149,627 +34% 0.01% $39,832,588
BANK OF AMERICA CORP /DE/ 0.71% 1,705,559 -2.8% 0% $31,604,008
ASHFORD CAPITAL MANAGEMENT INC 0.71% 1,700,285 +34% 3.5% $31,506,281
PRINCIPAL FINANCIAL GROUP INC 0.69% 1,657,712 +26% 0.02% $30,717,403
Greenhaven Road Investment Management, L.P. 0.69% 1,653,047 +8.9% 13% $30,630,961
ROYAL BANK OF CANADA 0.64% 1,549,467 +71% 0.01% $28,712,000
Bank of New York Mellon Corp 0.63% 1,521,040 +18% 0.01% $28,184,879

Institutional Holders of Cellebrite DI Ltd. - Ordinary Shares, par value 0.00001 NIS per share (CLBT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 615,937 $11,245,801 +$915,784 $18.03 7
2025 Q3 129,424,107 $2,398,195,670 +$236,444,351 $18.53 194
2025 Q2 118,023,067 $1,888,023,265 +$96,376,127 $16.00 207
2025 Q1 111,091,356 $2,158,060,728 +$17,336,152 $19.43 196
2024 Q4 109,611,642 $2,414,743,153 +$172,628,937 $22.03 190
2024 Q3 92,027,552 $1,549,738,036 +$162,565,361 $16.84 162
2024 Q2 82,827,477 $989,795,174 +$84,273,008 $11.95 146
2024 Q1 75,864,626 $836,285,496 +$117,532,707 $11.08 138
2023 Q4 86,517,854 $748,725,177 +$75,873,899 $8.66 116
2023 Q3 53,304,550 $402,692,089 +$106,109,469 $7.65 93
2023 Q2 38,873,021 $279,822,194 +$12,002,094 $7.20 75
2023 Q1 37,362,412 $227,499,632 +$5,419,519 $6.09 57
2022 Q4 40,117,660 $174,910,523 -$3,630,060 $4.36 51
2022 Q3 41,084,252 $161,537,648 +$10,182,285 $3.92 43
2022 Q2 38,483,927 $196,125,190 -$3,326,950 $5.10 45
2022 Q1 38,618,479 $247,169,160 +$8,435,170 $6.40 49
2021 Q4 36,614,332 $293,619,620 +$8,905,659 $8.02 48
2021 Q3 21,734,465 $200,833,000 +$200,767,000 $9.26 25